2013-2028 Report on Global Orphan Drugs Market by Player, Region, Type, Application and Sales Channel

Published: Dec, 2018 | Pages: 117 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Orphan Drugs market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for Orphan Drugs from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Orphan Drugs market.

Leading players of Orphan Drugs including:
    Novartis AG
    Bristol-Myers Squibb Company
    Celgene Corporation
    F. Hoffmann-La Roche Ltd.
    Pfizer, Inc.
    Sanofi S.A.
    Alexion Pharmaceuticals, Inc.
    Eli Lilly and Company
    Novo Nordisk A/S
    AstraZeneca
    Eisai Co., Ltd.
    Daiichi Sankyo Company Limited
    Bayer AG
    GlaxoSmithKline
    Merck & Co., Inc.
    Johnson & Johnson
    Biogen, Inc.
    Shire
    Amgen, Inc.

Market split by Type, can be divided into:
    Oncology
    Gastrointestinal
    Pulmonary
    Neurology
    Hematology
    Cardio-vascular

Market split by Application, can be divided into:
    Hospital Pharmacies
    Specialty Pharmacies
    Retail pharmacies
    Others

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Orphan Drugs Market Overview
    1.1 Orphan Drugs Definition
    1.2 Global Orphan Drugs Market Size Status and Outlook (2013-2028)
    1.3 Global Orphan Drugs Market Size Comparison by Region (2013-2028)
    1.4 Global Orphan Drugs Market Size Comparison by Type (2013-2028)
    1.5 Global Orphan Drugs Market Size Comparison by Application (2013-2028)
    1.6 Global Orphan Drugs Market Size Comparison by Sales Channel (2013-2028)
    1.7 Orphan Drugs Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Orphan Drugs Market Segment Analysis by Player
    2.1 Global Orphan Drugs Sales and Market Share by Player (2016-2018)
    2.2 Global Orphan Drugs Revenue and Market Share by Player (2016-2018)
    2.3 Global Orphan Drugs Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Orphan Drugs Market Segment Analysis by Type
    3.1 Global Orphan Drugs Market by Type
        3.1.1 Oncology
        3.1.2 Gastrointestinal
        3.1.3 Pulmonary
        3.1.4 Neurology
        3.1.5 Hematology
    3.2 Global Orphan Drugs Sales and Market Share by Type (2013-2018)
    3.3 Global Orphan Drugs Revenue and Market Share by Type (2013-2018)
    3.4 Global Orphan Drugs Average Price by Type (2013-2018)
    3.5 Leading Players of Orphan Drugs by Type in 2017
    3.6 Conclusion of Segment by Type
Chapter 4 Orphan Drugs Market Segment Analysis by Application
    4.1 Global Orphan Drugs Market by Application
        4.1.1 Hospital Pharmacies
        4.1.2 Specialty Pharmacies
        4.1.3 Retail pharmacies
        4.1.4 Others
    4.2 Global Orphan Drugs Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Orphan Drugs by Application in 2017
    4.4 Conclusion of Segment by Application
Chapter 5 Orphan Drugs Market Segment Analysis by Sales Channel
    5.1 Global Orphan Drugs Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Orphan Drugs Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Orphan Drugs by Sales Channel in 2017
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Orphan Drugs Market Segment Analysis by Region
    6.1 Global Orphan Drugs Market Size and CAGR by Region (2013-2028)
    6.2 Global Orphan Drugs Sales and Market Share by Region (2013-2018)
    6.3 Global Orphan Drugs Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Orphan Drugs Market Share by Type
        6.4.3 North America Orphan Drugs Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Orphan Drugs Market Share by Type
        6.5.3 Europe Orphan Drugs Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Orphan Drugs Market Share by Type
        6.6.3 Asia-Pacific Orphan Drugs Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Orphan Drugs Market Share by Type in 2017
        6.7.3 South America Orphan Drugs Market Share by Application in 2017
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Orphan Drugs Market Share by Type
        6.8.3 Middle East & Africa Orphan Drugs Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Orphan Drugs Players
    7.1 Novartis AG
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Bristol-Myers Squibb Company
    7.3 Celgene Corporation
    7.4 F. Hoffmann-La Roche Ltd.
    7.5 Pfizer, Inc.
    7.6 Sanofi S.A.
    7.7 Alexion Pharmaceuticals, Inc.
    7.8 Eli Lilly and Company
    7.9 Novo Nordisk A/S
    7.10 AstraZeneca
    7.11 Eisai Co., Ltd.
    7.12 Daiichi Sankyo Company Limited
    7.13 Bayer AG
    7.14 GlaxoSmithKline
    7.15 Merck & Co., Inc.
    7.16 Johnson & Johnson
    7.17 Biogen, Inc.
    7.18 Shire
    7.19 Amgen, Inc.
Chapter 8 Upstream and Downstream Analysis of Orphan Drugs
    8.1 Industrial Chain of Orphan Drugs
    8.2 Upstream of Orphan Drugs
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Orphan Drugs
        8.3.1 Leading Distributors/Dealers of Orphan Drugs
        8.3.2 Leading Consumers of Orphan Drugs
Chapter 9 Development Trend of Orphan Drugs (2018-2028)
    9.1 Global Orphan Drugs Market Size (Sales and Revenue) Forecast (2018-2028)
    9.2 Global Orphan Drugs Market Size and CAGR Forecast by Region (2018-2028)
    9.3 Global Orphan Drugs Market Size and CAGR Forecast by Type (2018-2028)
    9.4 Global Orphan Drugs Market Size and CAGR Forecast by Application (2018-2028)
    9.5 Global Orphan Drugs Market Size Forecast by Sales Channel (2018-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Orphan Drugs Example
    Figure Global Orphan Drugs Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Orphan Drugs Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Orphan Drugs Sales Comparison by Type (2013-2028)
    Figure Global Orphan Drugs Sales Comparison by Application (2013-2028)
    Figure Global Orphan Drugs Sales Comparison by Sales Channel (2013-2028)
    Table Global Orphan Drugs Sales by Player (2016-2018)
    Table Global Orphan Drugs Sales Market Share by Player (2016-2018)
    Figure Global Orphan Drugs Sales Market Share by Player in 2017
    Table Global Orphan Drugs Revenue (Million $) by Player (2016-2018)
    Table Global Orphan Drugs Revenue Market Share by Player (2016-2018)
    Figure Global Orphan Drugs Revenue Market Share by Player in 2017
    Table Global Orphan Drugs Average Price by Player (2016-2018)
    Figure Global Orphan Drugs Average Price by Player in 2017
    Figure Global Orphan Drugs Players Competition Situation - Top 5 Players' Revenue Market Share in 2017
    Figure Global Orphan Drugs Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Oncology
    Figure Global Oncology Sales and Growth Rate (2013-2018)
    Figure Example of Gastrointestinal
    Figure Global Gastrointestinal Sales and Growth Rate (2013-2018)
    Figure Example of Pulmonary
    Figure Global Pulmonary Sales and Growth Rate (2013-2018)
    Figure Example of Neurology
    Figure Global Neurology Sales and Growth Rate (2013-2018)
    Figure Example of Hematology
    Figure Global Hematology Sales and Growth Rate (2013-2018)
    Table Global Orphan Drugs Sales by Type (2013-2018)
    Table Global Orphan Drugs Sales Market Share by Type (2013-2018)
    Figure Global Orphan Drugs Sales Market Share by Type in 2017
    Table Global Orphan Drugs Revenue (Million $) by Type (2013-2018)
    Table Global Orphan Drugs Revenue Market Share by Type (2013-2018)
    Figure Global Orphan Drugs Revenue Market Share by Type in 2017
    Table Global Orphan Drugs Average Price by Type (2013-2018)
    Figure Global Orphan Drugs Average Price by Type in 2017
    Table Leading Players of Orphan Drugs by Type in 2017
    Figure Example of Hospital Pharmacies
    Figure Global Orphan Drugs for Hospital Pharmacies Sales and Growth Rate (2013-2018)
    Figure Example of Specialty Pharmacies
    Figure Global Orphan Drugs for Specialty Pharmacies Sales and Growth Rate (2013-2018)
    Figure Example of Retail pharmacies
    Figure Global Orphan Drugs for Retail pharmacies Sales and Growth Rate (2013-2018)
    Figure Example of Others
    Figure Global Orphan Drugs for Others Sales and Growth Rate (2013-2018)
    Table Global Orphan Drugs Sales by Application (2013-2018)
    Table Global Orphan Drugs Sales Market Share by Application (2013-2018)
    Figure Global Orphan Drugs Sales Market Share by Application in 2017
    Table Leading Consumers of Orphan Drugs by Application in 2017
    Figure Example of Direct Channel
    Figure Global Orphan Drugs for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Orphan Drugs for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Orphan Drugs Sales by Sales Channel (2013-2018)
    Table Global Orphan Drugs Sales Market Share by Sales Channel (2013-2018)
    Figure Global Orphan Drugs Sales Market Share by Sales Channel in 2017
    Table Leading Distributors/Dealers of Orphan Drugs by Sales Channel in 2017
    Table Global Orphan Drugs Market Size and CAGR by Region (2013-2028)
    Table Global Orphan Drugs Sales by Region (2013-2018)
    Table Global Orphan Drugs Sales Market Share by Region (2013-2018)
    Figure Global Orphan Drugs Sales Market Share by Region in 2017
    Table Global Orphan Drugs Revenue (Million $) by Region (2013-2018)
    Table Global Orphan Drugs Revenue Market Share by Region (2013-2018)
    Figure Global Orphan Drugs Revenue Market Share by Region in 2017
    Table North America Orphan Drugs Sales by Country (2013-2018)
    Figure North America Orphan Drugs Sales Market Share by Country (2013-2018)
    Table North America Orphan Drugs Revenue by Country (2013-2018)
    Figure North America Orphan Drugs Revenue Market Share by Country (2013-2018)
    Figure North America Orphan Drugs Sales Market Share by Type in 2017
    Figure North America Orphan Drugs Sales Market Share by Application in 2017
    Figure United States Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure United States Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Canada Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Mexico Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Orphan Drugs Sales by Country (2013-2018)
    Figure Europe Orphan Drugs Sales Market Share by Country (2013-2018)
    Table Europe Orphan Drugs Revenue by Country (2013-2018)
    Figure Europe Orphan Drugs Revenue Market Share by Country (2013-2018)
    Figure Europe Orphan Drugs Sales Market Share by Type in 2017
    Figure Europe Orphan Drugs Sales Market Share by Application in 2017
    Figure Germany Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Germany Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure UK Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure France Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Italy Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Russia Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Spain Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Orphan Drugs Sales by Country (2013-2018)
    Figure Asia-Pacific Orphan Drugs Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Orphan Drugs Revenue by Country (2013-2018)
    Figure Asia-Pacific Orphan Drugs Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Orphan Drugs Sales Market Share by Type in 2017
    Figure Asia-Pacific Orphan Drugs Sales Market Share by Application in 2017
    Figure China Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure China Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Japan Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Korea Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure India Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Australia Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Orphan Drugs Sales by Country (2013-2018)
    Figure South America Orphan Drugs Sales Market Share by Country (2013-2018)
    Table South America Orphan Drugs Revenue by Country (2013-2018)
    Figure South America Orphan Drugs Revenue Market Share by Country (2013-2018)
    Figure South America Orphan Drugs Sales Market Share by Type in 2017
    Figure South America Orphan Drugs Sales Market Share by Application in 2017
    Figure Brazil Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Brazil Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Argentina Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Colombia Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Chile Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Orphan Drugs Sales by Country (2013-2018)
    Figure Middle East & Africa Orphan Drugs Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Orphan Drugs Revenue by Country (2013-2018)
    Figure Middle East & Africa Orphan Drugs Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Orphan Drugs Sales Market Share by Type in 2017
    Figure Middle East & Africa Orphan Drugs Sales Market Share by Application in 2017
    Figure Egypt Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Egypt Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure South Africa Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Orphan Drugs Sales and Growth Rate (2013-2018)
    Figure Nigeria Orphan Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Novartis AG
    Table Orphan Drugs Introduction of Novartis AG
    Table Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share of Novartis AG (2016-2018)
    Table Industrial Chain of Orphan Drugs
    Table Manufacturing Cost Structure of Orphan Drugs
    Table General Manufacturing Process of Orphan Drugs
    Table Leading Distributors/Dealers of Orphan Drugs
    Table Leading Consumers of Orphan Drugs
    Figure Global Orphan Drugs Sales and Growth Rate Forecast (2018-2028)
    Figure Global Orphan Drugs Revenue and Growth Rate Forecast (2018-2028)
    Table Global Orphan Drugs Market Size and CAGR Forecast by Region (2018-2028)
    Table Global Orphan Drugs Market Size and CAGR Forecast by Type (2018-2028)
    Table Global Orphan Drugs Market Size and CAGR Forecast by Application (2018-2028)
    Table Global Orphan Drugs Market Size and CAGR Forecast by Sales Channel (2018-2028)